$AVAV Cashflow Statement | Understand Stock

$AVAV

$125.45 +$2.20 (1.78%) Close

$AVAV Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2026 12 months to Apr 30, 2026	FY2025 12 months to Apr 30, 2025	FY2024 12 months to Apr 30, 2024	FY2023 12 months to Apr 30, 2023	FY2022 12 months to Apr 30, 2022
Operating activities
Net (loss) income
Net (loss) income from continuing operations
Adjustments to reconcile net (loss) income to cash used in operating activities:
Depreciation and amortization
Impairment of goodwill
(Gain)/Loss from equity method investments
Loss on deconsolidation of previously controlled subsidiary
Amortization of debt issuance costs
Provision for credit losses
Reserve for inventory excess and obsolescence
Other non-cash expense, net
Non-cash lease expense
Loss on foreign currency transactions
(Gain) loss on sale of equity securities, net
Deferred income taxes
Stock-based compensation
Loss on disposal of property and equipment
Amortization of debt securities
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable
Unbilled receivables and retentions
Inventories
Income taxes receivable
Prepaid expenses and other assets
Accounts payable
Other liabilities

Net cash (used in) provided by operating activities

Investing activities
Acquisition of property and equipment
Acquisition of capitalized software to be sold
Contributions in equity method investments
Equity security investments
Purchase of available-for-sale investments
Other
Redemption of available-for-sale investments
Purchase of equity and debt investments
Proceeds from sale of equity securities
Acquisition of intangibles
Proceeds from deconsolidation of previously controlled subsidiary, net of cash deconsolidated
Business acquisitions, net of cash acquired
Proceeds from sale of ownership in equity method investment
Proceeds from loan repayment
Net cash used in investing activities

Financing activities
Proceeds from revolving credit facility
Principal payments of term loan
Principal payments of revolver
Proceeds from long-term debt
Proceeds from shares issued, net of underwriter costs
Payment of contingent consideration
Proceeds from shares issued, net of issuance costs
Proceeds from convertible debt, net of underwriter costs
Payment of debt issuance costs
Payment of equity issuance costs
Holdback and retention payments for business acquisition
Tax withholding payment related to net settlement of equity awards
Employee stock purchase plan contributions
Exercise of stock options
Other
Net cash provided by (used in) financing activities
Effects of currency translation on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosures of cash flow information
Cash paid, net during the period for:
Income taxes
Interest
Non-cash activities
Issuance of common stock for business acquisition
Unrealized gain on available-for-sale investments, net of deferred tax expense of $0 for the fiscal years ended April 30, 2023
Unrealized loss on available-for-sale investments
Change in foreign currency translation adjustments
Issuances of inventory to property and equipment, ISR in-service assets
Acquisitions of property and equipment included in accounts payable

Comments